Semaglutide is a GLP-1 receptor agonist that mimics the behavior of the GLP-1 hormone, which is naturally released after eating
From the cardiovascular system: tachycardia, arrhythmia, bradycardia, transverse heart block, cardiac arrest, peripheral vasodilation, collapse, pain in the heart, increased or decreased blood pressure, slowed heart conduction
Reconstitution: 2.0 mL per 5000 IU vial (2,500 IU/mL) for precise insulinsyringe measurements
Adding B12 does not change the weight loss number itself
Przerwy pomagaj organizmowi utrzyma rwnowag i unikn moliwego przyzwyczajenia
Data are limited, the risk is theoretical and requires thorough investigation prior to administration in individuals attempting conception